SureTrader Advertisement SureTrader
Home > Boards > Free Zone > Health and Sciences > Biotech Values

VX135 + Ribavirin: Enrollment in one study is

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
jq1234 Member Profile
 
Followed By 66
Posts 4,261
Boards Moderated 0
Alias Born 12/13/09
160x600 placeholder
Stocks End Higher; Nasdaq Snaps 7-day Losing Streak
Apple sees longest string of daily losses in 18 years Stocks closed higher and near session highs Monday, with the Nasdaq Composite...
Top Equities Stories Of The Day
FCC to Sell Maximum Amount in TV Airwave Auction
Hulu Bets on Cable-Style Web TV
Ackman: No Plans to Sell Any Valeant `Crown Jewel' Assets -CNBC
Amazon Kindle Oasis Video Review: Up Close With the Luxury E-Reader
Brazilian Judge Puts Temporary Ban on WhatsApp -- Update
Ford Profit Doubles as New Models Soar -- WSJ
Abbott to Acquire St. Jude -- WSJ
Baker Hughes Outlines Cost Cuts as Halliburton Deal Dies
jq1234   Tuesday, 04/30/13 06:49:53 PM
Re: DewDiligence post# 160555
Post # of 201092 
VX135 + Ribavirin: Enrollment in one study is complete, expect data 2nd half this year. I suppose most likely at AASLD in Nov.

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist